SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA

被引：0
|
作者：
Green, Sage [1 ]
Walter, Andrew [1 ]
Piatt, Joseph [1 ]
Kaur, Gurcharanjeet [1 ]
机构：
[1] Nemours AI duPont Hosp Children, Wilmington, DE USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LGG-12
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations
    Bouffet, Eric
    Hansford, Jordan R.
    Garre, Maria Luisa
    Hara, Junichi
    Plant-Fox, Ashley
    Aerts, Isabelle
    Locatelli, Franco
    van der Lugt, Jasper
    Papusha, Ludmila
    Sahm, Felix
    Tabori, Uri
    Cohen, Kenneth J.
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Larissa
    Bento Pereira da Silva, Ana
    Russo, Mark
    Hargrave, Darren R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (12): : 1108 - 1120
  • [22] Impressive and durable clinical responses obtained with dabrafenib and trametinib in low-grade serous ovarian cancer harbouring a BRAF V600E mutation
    Lima, Barbara
    Abreu, Miguel Henriques
    Sousa, Susana
    Bartosch, Carla
    Pereira, Deolinda
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 40
  • [23] Dabrafenib in advanced melanoma with BRAF V600E mutation
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (02): : 48 - 49
  • [24] Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
    Burger, Michael C.
    Ronelenfitsch, Michael W.
    Lorenz, Nadja I.
    Wagner, Marlies
    Voss, Martin
    Capper, David
    Tzaridis, Theophilos
    Herlinger, Ulrich
    Steinbach, Joachim P.
    Stoffels, Gabriele
    Langen, Karl-Josef
    Brandts, Christian
    Senft, Christian
    Harter, Patrick N.
    Baehr, Oliver
    ONCOLOGY REPORTS, 2017, 38 (06) : 3291 - 3296
  • [25] DABRAFENIB IN PATIENTS WITH RECURRENT, BRAF V600E MUTATED MALIGNANT GLIOMA AND LEPTOMENINGEAL DISEASE
    Burger, Michael
    Ronellenfitsch, Michael
    Lorenz, Nadja
    Wagner, Marlies
    Voss, Martin
    Capper, David
    Tzaridis, Theophilos
    Herrlinger, Ulrich
    Steinbach, Joachim
    Stoffels, Gabriele
    Langen, Karl-Josef
    Brandts, Christian
    Senft, Christian
    Harter, Patrick
    Baehr, Oliver
    NEURO-ONCOLOGY, 2017, 19 : 217 - 217
  • [26] Salvage chemotherapy after failure of targeted therapy in a child with BRAF V600E low-grade glioma
    Raswoli, Musthafa
    Nobre, Liana
    Hawkins, Cynthia
    Bartels, Ute Katharina
    Tabori, Uri
    Bouffet, Eric
    PEDIATRIC BLOOD & CANCER, 2021, 68 (01)
  • [27] Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real World Setting
    Auliac, J. B.
    Bayle, S.
    Do, P.
    Legarff, G.
    Guisier, F.
    Roa, M.
    Falchero, L.
    Huchon, E.
    Quere, G.
    Jeannin, G.
    Doubre, H.
    Baud, M.
    Hobeika, J.
    Chouaid, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S857 - S857
  • [28] Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report
    Gowda, Sonia
    Sandow, Lyndsey
    Heinrich, Michael C.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 788 - 793
  • [29] Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
    Marks, Asher M.
    Bindra, Ranjit S.
    DiLuna, Michael L.
    Huttner, Anita
    Jairam, Vikram
    Kahle, Kristopher T.
    Kieran, Mark W.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (05)
  • [30] Combination of Dabrafenib and Trametinib for the Treatment of Relapsed and Refractory Multiple Myeloma Harboring BRAF V600E Mutation
    Cepulyte, Ruta
    Zucenka, Andrius
    Peceliunas, Valdas
    CASE REPORTS IN HEMATOLOGY, 2020, 2020
12345